The Cardiometabolic and Lipids DSN is a collaborative community of AACE members dedicated to advancing the prevention, diagnosis, and management of cardiometabolic diseases, dyslipidemia, obesity, metabolic syndrome, and cardiovascular risk reduction. Our members represent a diverse group of endocrinologists and healthcare professionals who share a commitment to improving patient outcomes through evidence-based, patient-centered care. As the burden of cardiometabolic disease continues to rise globally, our mission is to provide timely, practical, and scientifically rigorous resources that empower clinicians to deliver optimal care.

Each year, our leadership group establishes strategic goals focused on education, research, advocacy, and clinical excellence. We actively contribute to AACE educational initiatives, clinical guidance documents, scientific publications, and multidisciplinary collaborations that address the evolving landscape of cardiometabolic health.

The Cardiometabolic and Lipids DSN serves as a trusted source of expertise within AACE and collaborates with national and international organizations to advance awareness, innovation, and best practices in lipid management, obesity medicine, diabetes care, and cardiovascular disease prevention.

We invite you to join our Cardiometabolic and Lipids Disease State Network and become part of a dynamic community dedicated to transforming the lives of patients through excellence in education, research, and clinical practice.

LEADERSHIP
TEAM

Abhishek Shrivastava, MD, MMsc, DMsc, PGD, FACE
Chair

Javier Morales, MD, FACP, FACE
Vice Chair

Julia Blanchette, PhD, RN, BC-ADM, CDCES, FADCES
Leader, National Meetings Workgroup

Scott Jafarian-Kerman, MD
Leader, Scientific Workgroup

Eliot Brinton, MD, FAHA, FNLA, FACE
Leader, Online Resources Workgroup